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In the last two decades, the management of urolithiasis
has changed profoundly. Ever since the introduction of
extracorporeal shock wave lithotripsy (SWL) in 1980
[1,2], it has become the first-line therapy for most renal
and ureteral stones. Nevertheless, the optimal treat-
ment for a large and impacted proximal ureteral stone
remains controversial. The outcome of SWL for ure-
teral stones is determined by various factors, includ-
ing stone size, location, and composition [3]. Large
ureteral stones may require several treatment sessions
with SWL.
Percutaneous nephrostolithotomy (PCNL) was
introduced as an alternative treatment for large renal
and proximal ureteral stones, and achieved success in
the 1980s [4]. Recently, with the advances in smaller
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The optimal treatment for large, impacted, proximal ureteral stones remains controversial. We report
our experience and compare treatment outcomes in patients with single, impacted, proximal
ureteral stones undergoing percutaneous nephrolithotomy (PCNL) and ureteroscopic lithotripsy
(URSL). Between January 2005 and January 2006, a total of 53 consecutive patients with solitary,
impacted, proximal ureteral stones > 15 mm in diameter who had undergone PCNL or URSL
treatments were enrolled in this study. The mean age was 48.5 ± 11.8 years. PCNL and URSL were
performed in 22 and 31 patients. Stone burdens in the PCNL and URSL groups were 232.8 ±
113.2 mm2 and 150.3 ± 70.3 mm2, respectively. The efficiency quotient (EQ) for the PCNL and URSL
groups was 0.95 and 0.67, respectively. The stone-free rate at the 1 month follow-up was 95.4% 
in the PCNL group and 58% in the URSL group (p < 0.001). Two patients in the PCNL group had
blood loss requiring transfusion. Eight patients had stones showing upward migration during
the URSL procedure, and these stones were subsequently treated by extracorporeal shock wave
lithotripsy and PCNL. For an impacted, proximal ureteral stone > 15 mm in diameter, PCNL had
better stone-free rates and could simultaneously treat coexisting renal stones. However, URSL
had the advantages of shorter operative times, shorter postoperative hospital stays, and fewer
postoperative complications.
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caliber semi-rigid and flexible ureteroscopes, uretero-
scopic lithotripsy (URSL) has reached a good stone-
free rate for lower ureteral stones and decreased the
risk of complications [5]. Although open surgery is
rarely used as first-line therapy, patients with large,
impacted, proximal ureteral stones may sometimes
require open surgery or laparoscopic ureterolithotomy.
Herein, we report our experience of the manage-
ment of impacted, proximal ureteral stones > 15 mm
in diameter and compare the treatment outcomes in
patients undergoing PCNL and URSL. In so doing,
we have attempted to determine the optimal thera-
peutic modality for patients with large, impacted,
proximal ureteral stones.
MATERIALS AND METHODS
Fifty-three consecutive patients presenting with a
solitary, impacted, proximal ureteral stone between
January 2005 and January 2006 were enrolled in this
study. The advantages, related complications of either
method of treatment and the possibility of conver-
sion to open surgery were explained to the patients
preoperatively.
The inclusion criteria for treatment were: (1) radio-
opaque upper ureteral stone > 15 mm in diameter by
plain film of kidney, ureter and bladder; (2) ureteral
stone located between the upper border of the L5 ver-
tebral body and the ureteropelvic junction (UPJ); and
(3) intravenous pyelogram (IVP) confirming impaction
of a stone with no visible contrast media below the
calculus on any IVP images. Patients with the follow-
ing conditions were excluded from the study: renal
insufficiency with a creatinine > 3.5 mg/dL, history of
previous irradiation or pelvic surgery, morbid obesity,
and coagulopathy.
PCNL was performed using the standard tech-
nique of puncture and placement of a nephrostomy
tract. The nephrostomy tract was created the day be-
fore surgery. The middle posterior calyx was chosen
for needle puncture. A core guide wire was negoti-
ated into the renal pelvis and across the UPJ into the
ureter. The guide wire was coiled into the calyces to
prevent it from being dislocated from the kidney
inadvertently. A 10-mm diameter, 8-cm long high-
pressure balloon dilation catheter (BlueMax; Boston
Scientific, Watertown, MA, USA) was used and the
nephrostomy tract was dilated to 30 F. The second
day, PCNL was performed under general anesthesia
with the patient in the prone position. A 26 F rigid
nephroscope or semirigid 7 F ureteroscope was intro-
duced through a 30 F Amplatz sheath along the guide
wire. Once the proximal ureteral stone was visible,
the stone was broken with a LithoClast Ultra (EMS,
Nyon, Switzerland), a combination ultrasonic and
pneumatic lithotripter unit, and the stone fragments
were removed. A double-J catheter was inserted if
possible, and a nephrostomy tube was left in place
for a few days.
URSL was performed with a semi-rigid Storz 6.5 F
or Wolf 7 F ureteroscope under epidural anesthesia 
in the lithotomy position. A ureteral guide wire was
used without dilating the ureteral orifice. The stones
were fragmented with the LithoClast Ultra or an elec-
trohydraulic lithotripter according to the surgeon’s
preference. A double-J catheter was placed in patients
with intraluminal mucosa edema, ureteral polyps, or
ureteral strictures.
Stone-free was defined as no residual stones de-
tected on plain abdomen X-ray film 1 month after ther-
apy. We used the efficiency quotient (EQ) to compare
the efficiency of both treatment groups. EQ was cal-
culated by the equation: EQ = [percentage stone-free/
(100%+percentage requiring retreatment+percentage
requiring an auxiliary procedure) [6].
The results are presented as mean ± standard de-
viation. All of the parameters were analyzed statisti-
cally using the unpaired Student’s t test and χ2 test. 
A p value <0.05 was considered statistically significant.
RESULTS
A total of 53 patients were included in this study, of
whom 22 were treated by PCNL and 31 were treated
by URSL. The patient demographic and clinical char-
acteristics are summarized in Table 1. There were no
significant differences in age, gender, calculus size, and
serum BUN level between the two groups of patients.
The stone burden was significantly greater in the PCNL
group than in the URSL group (232.8 ± 113.2 mm2 vs.
150.3±70.3 mm2, p=0.006) and the creatinine level was
higher in the URSL group.
The stone-free rate at the 1 month follow-up visit
after initial treatment was 95.4% in the PCNL group
and 58% in the URSL group (p < 0.001). The mean
treatment time and postoperative hospital stay were
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significantly lower in the URSL group than in the
PCNL group. Ten (45.4%) patients in the PCNL group
had a proximal ureteral stone combined with renal
stones; both the renal and proximal ureteral stones
were removed simultaneously during the same ses-
sion in all but one patient. The EQs for the PCNL and
URSL groups were 0.95 and 0.67, respectively.
Complications included blood loss requiring trans-
fusion, ascending stones, transient postoperative fever,
flank pain, and hematuria (Table 2). In the PCNL group,
there were six patients who had a transient postop-
erative fever, which was controlled with appropriate
antibiotics and supportive treatment. Two patients had
massive blood loss requiring transfusion. One patient
experienced a delayed renal hemorrhage and transar-
terial embolization of traumatic aneurysm was per-
formed for a pararenal hematoma and massive blood
loss. No urinary tract perforation or adjacent organ
injury occurred during the procedure. One patient had
steinstrasse over the distal ureter after PCNL treatment,
but the stone passed spontaneously within 1 week
after sufficient hydration and irrigation through the
nephrostomy tube. In the URSL group, there were
two patients who had episodes of a transient fever, 10
patients who had gross hematuria, and eight patients
who had stones showing upward migration during
the procedure; seven of these stones were subsequently
treated by SWL and one patient underwent PCNL
treatment. Upward migrating stone fragments were
the leading cause of URSL treatment failure. In one
patient, the stone could not be reached due to the tortu-
osity and angulation of the ureter; therefore, he under-
went open ureterolithotomy. There were no major
complications in the URSL group.
DISCUSSION
Long-term impacted ureteral stones may cause inter-
ruption of urinary flow and progressive backpressure
on the ureter and kidneys, resulting in hydroure-
teronephrosis. The increased backflow resulting from
intrapelvic pressure leads to a decline in renal blood
flow with progressive focal ischemia, compression of
Table 1. Demographic and clinical characteristics of patients in the percutaneous nephrolithotomy (PCNL) and
ureteroscopic lithotripsy (URSL) groups*
PCNL group (n = 22) URSL group (n = 31) p
Age (yr) 48.2 ± 11.2 48.9 ± 12.5 0.346
Men/Women 16/6 23/8 0.46
BUN (mg/dL) 15.41 ± 5.5 19.67 ± 7.78 0.403
Creatinine (mg/dL) 1.22 ± 0.25 1.75 ± 0.76 0.002
Stone laterality, R/L 9/13 13/18 0.204
Stone size (mm) 20.1 ± 5.4 18.6 ± 6.3 0.785
Stone burden (mm2) 232.8 ± 113.2 150.3 ± 70.3 0.006
*Data presented as mean ± standard deviation or n. BUN = blood, urea, nitrogen; R = right; L = left.
Table 2. Stone-free rate, operative finding and postoperative complications in patients in the percutaneous nephrolitho-
tomy (PCNL) and ureteroscopic lithotripsy (URSL) groups*
PCNL group (n = 22) URSL group (n = 31) p
Stone free 21 (95.4) 18 (58) 0.001
Mean treatment time (min) 115.4 ± 49.5 88.6 ± 28.5 0.009
Postoperative hospital stay (d) 4.7 ± 2.0 1.9 ± 1.1 0.038
Operation-related complications
Fever 6 (27.2) 2 (6.5)
Pain 8 (36.3) 6 (19.4)
Hematuria 12 (54.5) 7 (22.6)
Blood loss required transfusion 2 (9.1) 0
Stone upward migration 0 8 (25.8)
*Data presented as n (%) or mean ± standard deviation.
the papillae with a decrease in the glomerular filtration
rate, and thinning of the parenchyma due to a loss of
nephrons. Significant cortical atrophy will ultimately
result in renal function impairment [7].
The optimal management for ureteral stones is
still a subject of debate, especially for large, impacted,
proximal ureteral stones. SWL has the advantages of
an outpatient procedure, minimal requirements for
anesthesia, and a low complication rate. However,
stone burden, stone composition, and degree of stone
impaction are the main variables affecting the stone-
free rate after SWL. The impacted stones may be
resistant to shock wave disintegration. This phenom-
enon can be explained by the expansion space theory,
in which stones impacted in the ureteral mucosa
have no natural expansion space and no water-stone
interface, which are critical for calculi fragmentation
[8,9]. The high retreatment rate often prohibits SWL
as a first-line treatment for a large, impacted, proximal
ureteral stone [10,11].
Ureteroscopic lithotripsy was initially introduced
as a technique for managing distal ureteral stones and
has achieved a high success rate [8]. Because of the
improvement in fiberoptics and small caliber semi-
rigid ureteroscopes, we can now directly access the
whole ureter without ureteral dilatation. Irrespective
of the stone size, Park et al [12] reported an overall
stone-free rate of 87.8%. In URSL combined with dif-
ferent kinds of lithotripters, the stone-free rate ranges
widely from 35% to 87% for proximal ureteral stones
> 15 mm in diameter [9–11]. PCNL can achieve a total
stone-free rate from 86% to 98.5% for stone sizes
> 15 mm in diameter, which is superior to that with
any other treatment [13,14]. In the current study, the
stone-free rate was 95.8% in the PCNL group at the 
1-month follow-up visit. The other advantage of PCNL
is that any associated renal stones can be removed
simultaneously. In our series, 10 patients had com-
bined renal stones and we were able to remove both
renal and proximal ureteral stones simultaneously in
nine of these patients.
The complications observed with URSL mainly de-
pend on the surgeon’s experiences and skills. The most
serious complication is ureteral perforation, which is
reported with an incidence of 2–25% [5,11]. Most of
these perforations are minor and can be managed by
ureteral stents. Some severe perforations may need
conversion to an open ureterolithotomy for further
ureteral repair. Other complications include ascending
stones, postoperative fever, gross hematuria, and ure-
teral strictures. Upward migration of ureteral stone
fragments is the leading cause of incomplete URSL
treatment [15,16]. Continuous high-pressure irrigation
for obtaining a clear operative visual field may result
in an ascending stone. A pneumatic lithotripter is a
power lithotripter to fragment all types of stones and is
cheaper than the holmium:yttrium-aluminum-garnet
(Ho:YAG) laser. However, with the pneumatic litho-
tripter, there is a greater chance of producing ascend-
ing stones. Seven patients in the URSL group needed
auxiliary SWL for ascending stones. Dretler [17] de-
signed a stone cone for preventing and minimizing
ascending stones during the URSL procedure. How-
ever, all ureteral stones in our series were impacted
in the ureteral mucosa, where there is no additional
space for passing the wire of the stone cone.
Complications of bleeding can be managed con-
servatively in most cases; only about 2–5% of patients
need blood transfusion and arterial embolization is
rarely required [18]. With preoperative prophylactic
broad-spectrum intravenous antibiotics, the present
incidence of transient fever was 25% and no patient
experienced severe sepsis. All the transient fevers were
managed conservatively. Urinary tract perforation,
including the renal pelvis or ureter, is seen in some
series [18–20]. It is suggested that transfusion and
complication rates can be decreased to minimize the
nephrostomy tract to the diameter of a sheath that
will accept the nephroscope [19].
Using the concept of EQ, we can compare differ-
ent treatment results with the needs for retreatment
and auxiliary procedures. An ideal treatment has an
EQ of 1, and if the EQ is < 0.5, the treatment is consid-
ered insufficient because every patient requires an-
other treatment or auxiliary procedure to achieve 
a stone-free state. In our study, the EQs for the PCNL
and URSL groups were 0.95 and 0.67, respectively,
which is similar to other studies [10,11,21], demon-
strating the advantage of the PCNL treatment over
URSL therapy for large, proximal ureteral stones.
This investigation demonstrated that for large, 
impacted, proximal ureteral stones > 15 mm in diam-
eter, PCNL met the stone-free rate goals and simulta-
neously treated coexisting renal stones. URSL has the
advantages of less operative time, shorter postopera-
tive hospital stays and fewer postoperative complica-
tions, but the main disadvantages are the lower initial
stone-free rates and easy stone upward migration.
Comparison of antegrade and retrograde treatment of stones
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We suggest that only after discussing and under-
standing the stone-free success rate, cost-effectiveness,
and postoperative complications of these two differ-
ent treatments with the patients, could we choose the
optimal therapeutic modality for large, impacted,
proximal ureteral stones.
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